These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7750682)

  • 1. [Lansoprazole versus ranitidine in the prevention of early recurrences of digestive hemorrhages from gastroduodenal ulcers. Randomized double-blind multicenter study].
    Michel P; Duhamel C; Bazin B; Raoul JL; Person B; Bigard MA; Legoux JL; Sallerin V; Colin R
    Gastroenterol Clin Biol; 1994; 18(12):1102-5. PubMed ID: 7750682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
    Jensen DM; Pace SC; Soffer E; Comer GM;
    Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study.
    Villanueva C; Balanzó J; Torras X; Sáinz S; Soriano G; González D; Vilardell F
    Endoscopy; 1995 May; 27(4):308-12. PubMed ID: 7555936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
    Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
    Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
    Lazzaroni M; Bargiggia S; Bianchi Porro G
    Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally administered omeprazole versus injection therapy in the prevention of rebleeding from peptic ulcer with visible vessel. A multicenter randomized study.
    Bour B; Pariente EA; Hamelin B; Garcia E
    Gastroenterol Clin Biol; 1993; 17(5):329-33. PubMed ID: 8349066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
    Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
    Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
    Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
    Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
    Swarbrick ET; Gough AL; Foster CS; Christian J; Garrett AD; Langworthy CH
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):431-8. PubMed ID: 8804870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
    Lamouliatte H; Perie F; Joubert-Collin M
    Gastroenterol Clin Biol; 2000 May; 24(5):495-500. PubMed ID: 10891736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding.
    Mohamed SA; al Karawi MA
    Hepatogastroenterology; 1996; 43(10):863-5. PubMed ID: 8884305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.